MDA Staff

Blog Post

Clinical Trial Alert: ReveraGen BioPharma Seeks Participants for a Phase 2b DMD Study

By MDA Staff | March 12, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | March 5, 2019
Blog Post

MDA Releases New DMD Fact Sheet During Duchenne Muscular Dystrophy Awareness Week

By MDA Staff | February 13, 2019
MDA logo
Blog Post

Trexo Robotics Releases Trexo Home Walking Aid for Children

By MDA Staff | February 11, 2019
Blog Post

Arkansas to Screen Babies for SMA

By MDA Staff | February 7, 2019
clinical-trial-alert-image
Blog Post

Clinical Trial Alert: Brainstorm Cell Therapeutics Seeks Participants for a Phase 3 ALS Study

By MDA Staff | January 16, 2019
Blog Post

Newborn Screening for DMD and BMD: MDA Needs Your Help

By MDA Staff | January 15, 2019
clinical-trial-alert-image
Blog Post

Clinical Trial Alert: Orphazyme Seeks Participants for a Phase 3 ALS Study

By MDA Staff | January 11, 2019
clinical-trial-alert-image
Blog Post

Clinical Trial Alert: Catabasis Seeks Participants for a Phase 3 DMD Study

By MDA Staff | January 10, 2019
FDA APPROVED text on sticker on blue background with pen
Blog Post

FDA Announces the Approval of TIGLUTIK, an Oral Suspension Form of riluzole, for the Treatment of ALS

By MDA Staff | September 10, 2018